<html>
<head>PUBMED IDs for NPRL2</head>
<body bgcolor='#C5F0F2'><h1>NPRL2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11085536/'>The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.</a> November 21  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11980673/'>Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.</a> May 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15027117/'>RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.</a> March 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15374952/'>Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.</a> September 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15885884/'>Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.</a> May 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17018626/'>The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.</a> October 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19140316/'>[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].</a> February 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19274676/'>The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.</a> October 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19521502/'>A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex.</a> August 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20193080/'>Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.</a> December 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20700484/'>NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.</a> November 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22139571/'>Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.</a> April 3  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23046930/'>[Effect of recombinant plasmid pEGFP-N1-NPRL2 on the biological characteristics of human gastric cancer cells].</a> March 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23079973/'>NPRL2 gene expression in the progression of colon tumors.</a> July 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321467/'>NPRL2 is an independent prognostic factor of osteosarcoma.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24521741/'>Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.</a> April 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24789683/'>Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.</a> July 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25777765/'>Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.</a> January 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26044952/'>Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines.</a> May 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26112163/'>Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.</a> February 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26455908/'>Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.</a> October 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26505888/'>Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.</a> June 18  2015<br></body></html>
